APP and Alzheimer disease: Evidence from amyloid precursor protein (APP) mouse models of AD have shown that both hetero- and homozygote tau deficiency rescued premature mortality and prevented memory deficits in transgenic mice expressing familial AD mutations in human APP (hAPP), which appeared to be conferred by reduced susceptibility to excitotoxicity in tau knockout mice18,19.